| Literature DB >> 35340077 |
Hajime Kato1,2, Anenya J Ansh3, Ethan R Lester3, Yuka Kinoshita1,2, Naoko Hidaka1,2, Yoshitomo Hoshino1,2, Minae Koga1,2, Yuki Taniguchi4, Taisuke Uchida5, Hideki Yamaguchi5, Yo Niida6, Masamitsu Nakazato5, Masaomi Nangaku1, Noriko Makita1,2, Toshinari Takamura7, Taku Saito2,4, Demetrios T Braddock3, Nobuaki Ito1,2.
Abstract
Homozygous ENPP1 mutations are associated with autosomal recessive hypophosphatemic rickets type 2 (ARHR2), severe ossification of the spinal ligaments, and generalized arterial calcification of infancy type 1. There are a limited number of reports on phenotypes associated with heterozygous ENPP1 mutations. Here, we report a series of three probands and their families with heterozygous and compound heterozygous ENPP1 mutations. The first case (case 1) was a 47-year-old male, diagnosed with early-onset osteoporosis and low-normal serum phosphate levels, which invoked suspicion for hypophosphatemic rickets. The second and third cases were 77- and 54-year-old females who both presented with severe spinal ligament ossification and the presumptive diagnosis of diffuse idiopathic skeletal hyperostosis (DISH). Upon workup, fibroblast growth factor 23 (FGF23) was noted to be relatively high in case 2 and serum phosphorous was low-normal in case 3, and the diagnoses of X-linked hypophosphatemic rickets (XLH) and ARHR2 were considered. Genetic testing for genes related to congenital hypophosphatemic rickets was therefore performed, revealing heterozygous ENPP1 variants in cases 1 and 2 (case 1, c.536A>G, p.Asn179Ser; case 2, c.1352A>G, p.Tyr451Cys) and compound heterozygous ENPP1 variants in case 3 constituting the same variants present in cases 1 and 2 (c.536A>G, p.Asn179Ser and c.1352A>G, p.Tyr451Cys). Several in silico tools predicted the two variants to be pathogeneic, a finding confirmed by in vitro biochemical analysis demonstrating that the p.Asn179Ser and p.Tyr451Cys ENPP1 variants possessed a catalytic velocity of 45% and 30% compared with that of wild-type ENPP1, respectively. Both variants were therefore categorized as pathogenic loss-of-function mutations. Our findings suggest that ENPP1 mutational status should be evaluated in patients presenting with the diagnosis of idiopathic DISH, ossification of the posterior longitudinal ligament (OPLL), and early-onset osteoporosis.Entities:
Keywords: DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS; EARLY-ONSET OSTEOPOROSIS; ENTHESOPATHY; FIBROBLAST GROWTH FACTOR 23; OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT; OSTEOPHYTE
Mesh:
Substances:
Year: 2022 PMID: 35340077 PMCID: PMC9177665 DOI: 10.1002/jbmr.4550
Source DB: PubMed Journal: J Bone Miner Res ISSN: 0884-0431 Impact factor: 6.390